TERIFLUNOMIDE/STADA
FORM
Film-coated tablet
STRENGTH
14 mg
INDICATIONS
Teriflunomide/Stada is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (MS)
Important note
The treatment should be initiated and supervised by a physician experienced in the management of multiple sclerosis.